Orthofix Medical Inc. (NASDAQ:OFIX) Shares Bought by Juniper Investment Company LLC

Juniper Investment Company LLC increased its stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 123.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,937,249 shares of the medical device company's stock after acquiring an additional 1,070,656 shares during the period. Orthofix Medical accounts for about 13.3% of Juniper Investment Company LLC's holdings, making the stock its 4th largest position. Juniper Investment Company LLC owned about 5.07% of Orthofix Medical worth $33,824,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Barclays PLC boosted its holdings in Orthofix Medical by 38.8% during the third quarter. Barclays PLC now owns 122,472 shares of the medical device company's stock valued at $1,912,000 after acquiring an additional 34,210 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Orthofix Medical by 480.7% in the third quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company's stock worth $1,318,000 after purchasing an additional 69,848 shares during the period. SG Americas Securities LLC lifted its position in shares of Orthofix Medical by 24.3% during the 4th quarter. SG Americas Securities LLC now owns 21,279 shares of the medical device company's stock worth $372,000 after purchasing an additional 4,162 shares during the last quarter. Kirr Marbach & Co. LLC IN bought a new stake in Orthofix Medical during the 4th quarter valued at approximately $532,000. Finally, R Squared Ltd acquired a new stake in Orthofix Medical in the 4th quarter valued at approximately $50,000. 89.76% of the stock is owned by institutional investors.

Orthofix Medical Stock Down 1.6 %

Shares of OFIX stock opened at $12.11 on Friday. The stock has a market cap of $472.56 million, a P/E ratio of -3.87 and a beta of 0.87. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The stock has a fifty day moving average price of $14.86 and a 200 day moving average price of $16.91. Orthofix Medical Inc. has a one year low of $10.50 and a one year high of $20.73.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Roth Mkm reiterated a "buy" rating and set a $22.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Canaccord Genuity Group reiterated a "buy" rating and set a $24.00 target price on shares of Orthofix Medical in a research note on Wednesday, February 26th. Finally, StockNews.com lowered shares of Orthofix Medical from a "buy" rating to a "hold" rating in a research report on Wednesday.

Insider Transactions at Orthofix Medical

In other news, insider Jorge Andres Cedron sold 3,816 shares of the business's stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total value of $50,790.96. Following the sale, the insider now owns 42,500 shares in the company, valued at approximately $565,675. The trade was a 8.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Engine Capital Management, Lp bought 100,000 shares of the stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average cost of $12.31 per share, for a total transaction of $1,231,000.00. Following the acquisition, the insider now owns 3,544,807 shares in the company, valued at $43,636,574.17. The trade was a 2.90 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders sold 8,475 shares of company stock valued at $128,065. Company insiders own 2.60% of the company's stock.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix Medical Inc. (NASDAQ:OFIX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.